Meten Holding Group Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares; Size Not Disclosed

Meten Holding Group Ltd. ("Meten Holding" or the "Company") (NASDAQ:METX), one of the leading omnichannel English language training ("ELT") service providers in China, today

Benzinga · 2021-09-01 16:41

Meten Holding Group Ltd. ("Meten Holding" or the "Company") (NASDAQ:METX), one of the leading omnichannel English language training ("ELT") service providers in China, today announced that it intends to offer in an underwritten public offering ordinary shares and pre-funded warrants to purchase ordinary shares ("Offering"). The pre-funded warrants shall be offered at the same price per share as the ordinary shares, less the $0.01 per share exercise price of each pre-funded warrant. The Company intends to use the net proceeds from this offering for general corporate and working capital needs. The ordinary shares are trading on The Nasdaq Capital Market under the symbol "METX." The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.

Aegis Capital Corp. is acting as the sole book-running manager for the offering.

The Offering is being made pursuant to an effective shelf registration statement on Form F-3 (No. 333-256087) previously filed with the U.S. Securities and Exchange Commission (the "SEC") and declared effective by the SEC on May 21, 2021. A preliminary prospectus supplement and accompanying prospectus describing the terms of the Offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Electronic copies of the preliminary prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital Corp., Attention: Syndicate Department, 810 7th Avenue, 18th floor, New York, NY 10019, by email at syndicate@aegiscap.com, or by telephone at (212) 813-1010. Before investing in this offering, interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.